AAV gene delivery to the spinal cord: serotypes, methods, candidate diseases, and clinical trials.

about

AAV gene delivery to the spinal cord: serotypes, methods, candidate diseases, and clinical trials.

Item

http://www.wikidata.org/entity/Q47564638

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

AAV gene delivery to the spina ...... diseases, and clinical trials.

@en

AAV gene delivery to the spina ...... diseases, and clinical trials.

@nl

type

Item

label

AAV gene delivery to the spina ...... diseases, and clinical trials.

@en

AAV gene delivery to the spina ...... diseases, and clinical trials.

@nl

prefLabel

AAV gene delivery to the spina ...... diseases, and clinical trials.

@en

AAV gene delivery to the spina ...... diseases, and clinical trials.

@nl

P1476

AAV gene delivery to the spina ...... diseases, and clinical trials.

@en

P2093

Nathan Hardcastle

http://www.w3.org/2001/XMLSchema#string

Thais Federici

http://www.w3.org/2001/XMLSchema#string

P2860

New mutations, genotype phenotype studies and manifesting carriers in giant axonal neuropathy

Controlling neuropathic pain by adeno-associated virus driven production of the anti-inflammatory cytokine, interleukin-10

Intrathecal long-term gene expression by self-complementary adeno-associated virus type 1 suitable for chronic pain studies in rats

A large animal model of spinal muscular atrophy and correction of phenotype.

Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis

Early heart failure in the SMNDelta7 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery

CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy.

Deficits in axonal transport precede ALS symptoms in vivo.

Expansive gene transfer in the rat CNS rapidly produces amyotrophic lateral sclerosis relevant sequelae when TDP-43 is overexpressed.

Viral delivery of antioxidant genes as a therapeutic strategy in experimental models of amyotrophic lateral sclerosis.

P304

293-307

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1080/14712598.2018.1416089

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nicholas M Boulis

P577

2017-12-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29249183

http://www.w3.org/2001/XMLSchema#string